Skip to main content
Caplight Logo









Kintsugi

Kintsugi

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://kintsugihealth.com

Last Round

Series A

Feb 23, 2022

Total Funding Raised

$28.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kintsugi is a healthcare technology company that develops voice biomarker infrastructure to detect signs of clinical depression and anxiety from short clips of free-form speech.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

voice biomarkermental health screeningdigital phenotypingclinical decision supportAI mental healthbehavioral health techelectronic health recordsEHRtelehealth integrationvocal biomarkerAPI-first healthcarespeech analysisAI diagnosticsusage-based SaaSmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kintsugi Comparables

Compare Kintsugi with similar companies based on industry and business-model similarity.

Kintsugi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Canary Speech
89%
Ellipsis Health
89%
Sonde Health
86%

Kintsugi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 23, 2022
SeedAug 26, 2021
AcceleratorAug 31, 2020
GrantJul 1, 2020
GrantOct 15, 2019

Key People

Founding team and executive leadership

Grace Chang

Founder CEO

Founding Team

Kintsugi Investors

Notable investors and investment history

Kintsugi investors
InvestorRounds
IT-Farm CorporationSeries A, Seed
Headwater VenturesSeed
TechstarsSeed, Accelerator
Side Door VenturesSeries A
Acrew CapitalSeries A, Seed
Citta CapitalSeries A, Seed
Primetime PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 43% MoM, reaching 7.9K.

  • Mar 27, 2025

    Haritha joins from Apple, where she managed SaMD clinical trials.

Kintsugi Filings

Explore SEC and related filing metadata, where available.

Kintsugi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kintsugi's valuation, stock price, and market status.

Is Kintsugi a public or private company?

Kintsugi is a private company.

What is the current stock price of Kintsugi?

Kintsugi is a private company, so its shares have no public market price. Caplight tracks Kintsugi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kintsugi worth (valuation)?

Valuation information for Kintsugi is not publicly available.

Can I buy Kintsugi stock?

Kintsugi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kintsugi's last funding round?

Kintsugi's most recent funding round was Series A on February 23, 2022.

Who are the main investors in Kintsugi?

Key investors in Kintsugi include Acrew Capital, Insight Partners.

Will Kintsugi IPO soon?

No public IPO plans have been announced for Kintsugi.

How can I track Kintsugi secondary market activity?

Caplight tracks bids, offers, and trades in Kintsugi's shares on secondary markets.

Firmographic Details

HeadquartersBerkeley, California
Employee Range12
Year Founded2019
Last FundingFeb 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?